Enbrel-Sulfasalazin-Early-Axial Spondyloarthritis (AS)
This study is currently recruiting participants.
Verified February 2009 by Charite University, Berlin, Germany
Sponsor:
Charite University, Berlin, Germany
Collaborator:
Wyeth is now a wholly owned subsidiary of Pfizer
Information provided by:
Charite University, Berlin, Germany
ClinicalTrials.gov Identifier:
NCT00844142
First received: February 12, 2009
Last updated: NA
Last verified: February 2009
History: No changes posted
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | July 2013 |
| Estimated Primary Completion Date: | July 2013 (Final data collection date for primary outcome measure) |